Tenderwize
Back to tender search

Open-house biologics rebate agreement for Triptorelin embonate

Techniker Krankenkasse·Hamburg, Germany·Deadline Sep 29, 2027 · 407 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-22 - Triptorelin embonat

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Offers/contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature...

Participation is limited to pharmaceutical entrepreneurs meeting AMG seat and authorisation requirements for the releva...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Conclusion of pharmaceutical rebate agreements under Section 130a(8) SGB V for the active substance Triptorelin embonate.
  • Open-house model with uniform terms for all suitable pharmaceutical companies; no individual contract negotiations.
Show full summary

Open-house pharmaceutical supply arrangement in Germany for Triptorelin embonate (CPV 33600000) led by Techniker Krankenkasse with hkk and HEK as participating buyers. The procedure is non-exclusive, with no individual negotiations and open accession possible throughout the contract period. The contract term runs from 01.10.2025 to 30.09.2027 at the latest, with automatic earlier end if patent/market exclusivity expires. No contract value is stated. Procurement documents are available via the portal, but only the notice/XML text was analyzed, not the full documents.

Risks

Offers/contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature...

Participation is limited to pharmaceutical entrepreneurs meeting AMG seat and authorisation requirements for the releva...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG for the relevant medicinal product.
  • Applicant must have its registered seat in the AMG territory, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-house biologics rebate agreement for Triptorelin embonate

Open-house agreement for pharmaceutical rebate contracts concerning the active substance Triptorelin embonate. Scope is nationwide in Germany and the arrangement is non-exclusive, with uniform conditions and no individual negotiations. The lot information comes from structured data and the XML notice.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Sep 29, 2027

Procurement Details

Publication date
07 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
521224-2025

Documents (1)

Similar tenders